(Q35450209)

8 August 2017

1 reference

title

Is fecal microbiota transplantation (FMT) an effective treatment for patients with functional gastrointestinal disorders (FGID)? (English)

1 reference

8 August 2017

0 references

D M Pinn

1

1 reference

8 August 2017

O C Aroniadis

series ordinal

2

1 reference

8 August 2017

L J Brandt

series ordinal

3

1 reference

8 August 2017

publication date

25 November 2014

1 reference

Neurogastroenterology and Motility

8 August 2017

published in

1 reference

8 August 2017

volume

27

1 reference

8 August 2017

issue

1

1 reference

8 August 2017

page(s)

19-29

1 reference

Epidemiology and health care seeking in the functional GI disorders: a population-based study.

8 August 2017

cites work

1 reference

The functional gastrointestinal disorders and the Rome III process

21 January 2018

1 reference

Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis

21 January 2018

1 reference

The impact of irritable bowel syndrome on health-related quality of life

21 January 2018

1 reference

21 January 2018

1 reference

Irritable bowel syndrome in twins: genes and environment

21 January 2018

1 reference

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

Peripheral factors in the pathophysiology of irritable bowel syndrome

21 January 2018

1 reference

Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria

21 January 2018

1 reference

The role of oxidants and reactive nitrogen species in irritable bowel syndrome: a potential etiological explanation

21 January 2018

1 reference

Interactions between commensal intestinal bacteria and the immune system

21 January 2018

1 reference

IgA responses in the intestinal mucosa against pathogenic and non-pathogenic microorganisms.

21 January 2018

1 reference

Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication that tunes innate immunity in large intestine

21 January 2018

1 reference

Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction.

21 January 2018

1 reference

Differential expression of toll-like receptors in patients with irritable bowel syndrome.

21 January 2018

1 reference

Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype

21 January 2018

1 reference

Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome

21 January 2018

1 reference

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome

21 January 2018

1 reference

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.

21 January 2018

1 reference

Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome

21 January 2018

1 reference

Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.

21 January 2018

1 reference

Intestinal microbiota and its role in irritable bowel syndrome (IBS).

21 January 2018

1 reference

The interplay between the intestinal microbiota and the brain

21 January 2018

1 reference

Gut feelings: the emerging biology of gut-brain communication

21 January 2018

1 reference

Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome.

21 January 2018

1 reference

Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses.

21 January 2018

1 reference

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

Anxiogenic effect of subclinical bacterial infection in mice in the absence of overt immune activation.

21 January 2018

1 reference

Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni

21 January 2018

1 reference

The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice

21 January 2018

1 reference

Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction

21 January 2018

1 reference

Antinociceptive effect of VSL#3 on visceral hypersensitivity in a rat model of irritable bowel syndrome: a possible action through nitric oxide pathway and enhance barrier function

21 January 2018

1 reference

Postinfectious irritable bowel syndrome--a meta-analysis

21 January 2018

1 reference

Postinfectious irritable bowel syndrome

21 January 2018

1 reference

Monitoring of stool microbiota in subjects with diarrhea indicates distortions in composition

21 January 2018

1 reference

Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter.

21 January 2018

1 reference

Bacteria and irritable bowel syndrome: the evidence for small intestinal bacterial overgrowth

21 January 2018

1 reference

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

21 January 2018

1 reference

Rifaximin therapy for patients with irritable bowel syndrome without constipation

21 January 2018

1 reference

Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth

21 January 2018

1 reference

A systematic review of diagnostic tests for small intestinal bacterial overgrowth

21 January 2018

1 reference

Use and abuse of hydrogen breath tests

21 January 2018

1 reference

Overgrowth of the indigenous gut microbiome and irritable bowel syndrome

21 January 2018

1 reference

Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective

21 January 2018

1 reference

Intestinal microecology and quality of life in irritable bowel syndrome patients

21 January 2018

1 reference

The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects

21 January 2018

1 reference

Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients

21 January 2018

1 reference

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

21 January 2018

1 reference

Diversity of the human gastrointestinal tract microbiota revisited.

21 January 2018

1 reference

Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment

21 January 2018

1 reference

Diarrhoea-predominant irritable bowel syndrome distinguishable by 16S rRNA gene phylotype quantification

21 January 2018

1 reference

An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota.

21 January 2018

1 reference

Temporal stability analysis of the microbiota in human feces by denaturing gradient gel electrophoresis using universal and group-specific 16S rRNA gene primers

21 January 2018

1 reference

Composition and temporal stability of gastrointestinal microbiota in irritable bowel syndrome--a longitudinal study in IBS and control subjects.

21 January 2018

1 reference

Interdigestive myoelectric complex in germ-free rats.

21 January 2018

1 reference

Short-chain fatty acids stimulate colonic transit via intraluminal 5-HT release in rats

21 January 2018

1 reference

Altered intestinal microbiota in irritable bowel syndrome

21 January 2018

1 reference

Luminal hydrogen sulfide plays a pronociceptive role in mouse colon

21 January 2018

1 reference

Mechanisms of microbial hydrogen disposal in the human colon and implications for health and disease

21 January 2018

1 reference

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection

21 January 2018

1 reference

Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection

21 January 2018

1 reference

Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease

21 January 2018

1 reference

Bacteriotherapy using fecal flora: toying with human motions

21 January 2018

1 reference

Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection

21 January 2018

1 reference

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis

21 January 2018

1 reference

Patient attitudes toward the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection

21 January 2018

1 reference

Review article: faecal transplantation therapy for gastrointestinal disease

21 January 2018

1 reference

Faecal microbiota transplantation: from practice to legislation before considering industrialization

21 January 2018

1 reference

Stool substitute transplant therapy for the eradication of Clostridium difficile infection: 'RePOOPulating' the gut.

21 January 2018

1 reference

Persistent intestinal neuromuscular dysfunction after acute nematode infection in mice

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/NMO.12479

1 reference

8 August 2017

1 reference